FT Options’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

FT Options’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$212K	Buy	+2,311	New	+$177K	0.32%	62
2017 Q2	–	Sell	-3,085	Closed	-$669K	–	301
2017 Q1	$669K	Buy	3,085 +2,974	+2,679%	+$425K	0.88%	30
2016 Q4	$10K	Buy	+111	New	+$12.5K	0.01%	203
2016 Q3	–	Sell	-2,434	Closed	-$242K	–	459
2016 Q2	$247K	Buy	2,434 +100	+4%	+$12.4K	0.21%	88
2016 Q1	$382K	Sell	2,334 -2,879	-55%	-$584K	0.4%	53
2015 Q4	$1.71M	Buy	+5,213	New	+$1.7M	1.26%	23

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

FT Options's LUMO Position: Q3 2017 in Review

FT Options opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017: 2,311 shares worth $212K. The stake represents 0.32% of the portfolio and ranks #62 among its holdings. This is a return to the name: FT Options previously reported a position in LUMO as recently as Q1 2017.

FT Options first reported a position in LUMO in Q4 2015 and has held it in 6 quarters since. The position peaked at $1.71M in Q4 2015. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

FT Options held 2,311 shares of Lumos Pharma, Inc. Common Stock worth $212K as of Q3 2017.
Lumos Pharma, Inc. Common Stock was a new FT Options position in Q3 2017.
Lumos Pharma, Inc. Common Stock made up 0.32% of FT Options's portfolio in Q3 2017, its #62 holding.
FT Options first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2015 and has held it in 6 quarters since.
FT Options's Lumos Pharma, Inc. Common Stock position peaked at $1.71M in Q4 2015.
126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.